Cerus Corporation (CERS) |
1.85 0.06 (3.35%) 05-07 16:00 |
Open: | 1.77 |
High: | 1.88 |
Low: | 1.765 |
Volume: | 1,079,471 |
Market Cap: | 342(M) |
PE Ratio: | -10.88 |
Exchange: | NASDAQ Global Market |
Industry: | Medical - Devices |
Sector: | Healthcare |
Technical analysis | ||||
sell | buy |
Resistance 2: | 2.34 |
Resistance 1: | 2.00 |
Pivot price: | 1.70 |
Support 1: | 1.76 |
Support 2: | 1.61 |
52w High: | 3.08 |
52w Low: | 1.21 |
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
EPS | -0.210 |
Book Value | 0.270 |
PEG Ratio | 0.00 |
Gross Profit | 0.000 |
Profit Margin (%) | -19.27 |
Operating Margin (%) | -20.80 |
Return on Assets (ttm) | -6.3 |
Return on Equity (ttm) | -57.8 |
Tue, 07 May 2024
Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Movies UK
Mon, 06 May 2024
Cerus (NASDAQ:CERS) PT Raised to $4.00 at Cantor Fitzgerald - Defense World
Mon, 06 May 2024
Cerus (CERS) Looks Good: Stock Adds 9.5% in Session - Yahoo Lifestyle UK
Sun, 05 May 2024
The Cerus Corporation (NASDAQ:CERS) First-Quarter Results Are Out And Analysts Have Published New Forecasts - Simply Wall St
Sat, 04 May 2024
What Kind Of Shareholders Hold The Majority In Cerus Corporation's (NASDAQ:CERS) Shares? - Yahoo Canada Shine On
Fri, 03 May 2024
Cerus stock PT raised to $4 at Cantor Fitzgerald, citing strong 1Q revenue By Investing.com - Investing.com
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |